Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Short Interest Update

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 4,000,000 shares, a drop of 19.4% from the September 30th total of 4,960,000 shares. Based on an average trading volume of 523,300 shares, […]

Related Keywords

United States ,America ,William Blair ,Bobakr Azamian ,Zurcher Kantonalbank Zurich Cantonalbank ,Elizabeth Yeu Lin ,Nasdaq ,Institutional Trading Of Tarsus Pharmaceuticals ,Mirae Asset Global Investments Co ,Allspring Global Investments Holdings ,Tarsus Pharmaceuticals Company Profile ,Tarsus Pharmaceuticals Inc ,Tarsus Pharmaceuticals Stock ,Raymond James Financial Services Advisors Inc ,Tarsus Pharmaceuticals ,Securities Exchange Commission ,News Ratings For Tarsus Pharmaceuticals Daily ,Raymond James Associates ,Get Free Report ,Exchange Commission ,Director Elizabeth Yeu Lin ,Global Investments Holdings ,Asset Global Investments ,Kantonalbank Zurich Cantonalbank ,James Financial Services Advisors ,Raymond James ,Tarsus Pharmaceuticals Daily ,Nasdaq Tars ,Stars ,Medical ,Stocks ,Options ,Put ,Call ,